LQV Branded Vial
Semaglutide
Includes syringes and alcohol pads with every vial shipment.
Semaglutide
(SMA)
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management and now widely used for weight management. It helps reduce appetite, slow gastric emptying, and promote sustainable weight loss when combined with lifestyle modifications.
How It Works
Semaglutide mimics the naturally occurring GLP-1 hormone, binding to GLP-1 receptors in the brain to reduce hunger signals and increase feelings of fullness. It also slows gastric emptying, allowing food to remain in the stomach longer, which contributes to reduced caloric intake over time.
Key Benefits
Who It Is For
Adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol. Candidates must undergo medical evaluation before starting therapy.
Common Side Effects
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are typically mild and tend to decrease as the body adjusts. Rare but serious risks include pancreatitis, gallbladder issues, and thyroid-related concerns. All risks are reviewed during consultation.
Other GLP-1 Therapies
GLP-1 Therapy
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two incretin pathways simultaneously. It has demonstrated significant efficacy in clinical weight loss trials and offers enhanced metabolic benefits compared to single-receptor therapies.
From $399
GLP-1 Therapy
Retatrutide
(RTA)
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. By engaging three metabolic pathways, it represents the next generation of weight management therapies with the potential for greater efficacy in both weight loss and metabolic improvement.
From $449
GLP-1 Therapy
Cagrilintide
Cagrilintide is a long-acting amylin analog that enhances satiety signaling. It works through a distinct mechanism from GLP-1 therapies, targeting the amylin pathway to help patients feel full sooner and reduce overall food intake.
From $349
Frequently Asked Questions
A therapy that mimics natural gut hormones involved in appetite and blood sugar regulation.
Yes. Medical evaluation and monitoring are required for all GLP-1 therapies.
Yes, following medical review and protocol setup.
Yes. Use the Speak To Our Medical Team tab to submit a form and request a consultation.
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.